Hassan Awada, MD, on AML and Machine Learning: Improving Prognostication

December 15, 2020 By The ASCO Post Staff

Hassan Awada, MD, of the Taussig Cancer Institute, Cleveland Clinic Foundation, discusses the use of newer machine-learning techniques to help decipher a set of prognostic subgroups that could predict survival, thus potentially improving on traditional methods and moving acute myeloid leukemia into the era of personalized medicine (Abstract 34).

Related Content